Viewing Study NCT04554459


Ignite Creation Date: 2025-12-24 @ 3:04 PM
Ignite Modification Date: 2026-01-29 @ 6:28 PM
Study NCT ID: NCT04554459
Status: TERMINATED
Last Update Posted: 2024-08-14
First Post: 2020-09-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph+ ALL
Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia, Adult View
None Ph+ ALL View
None Newly Diagnosed View
Keywords: